Psychology & Psychiatry

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement—ketamine—shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Psychology & Psychiatry

New study supports medical safety of electroconvulsive therapy (ECT)

Electroconvulsive therapy (ECT) is a medically safe mental health intervention, according to a new study led by CAMH researcher Dr. Tyler Kaster as part of his doctoral studies at ICES and the University of Toronto. The study ...

Medications

Nasal spray approved for treating suicidal people

Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about COVID-19's effect on the mental health of Americans.

Psychology & Psychiatry

Hospital study examines the cost-effectiveness of esketamine

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. Titled "Cost-Effectiveness of Esketamine Nasal ...

page 6 from 9